Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation.
Tapirdamaz Ö, Hesselink DA, el Bouazzaoui S, Azimpour M, Hansen B, van der Laan LJ, Polak WG, Kwekkeboom J, van Schaik RH, van Gelder T, Metselaar HJ. Tapirdamaz Ö, et al. Among authors: van gelder t, van der laan lj, van schaik rh. Pharmacogenet Genomics. 2014 Sep;24(9):427-35. doi: 10.1097/FPC.0000000000000063. Pharmacogenet Genomics. 2014. PMID: 25014506
[Twenty-five years of cyclosporin use in transplantation medicine].
Hesselink DA, van Hagen PM, Balk AH, van Hal PT, Weimar W, van Gelder T. Hesselink DA, et al. Among authors: van hagen pm, van gelder t, van hal pt. Ned Tijdschr Geneeskd. 2003 May 17;147(20):959-64. Ned Tijdschr Geneeskd. 2003. PMID: 12784529 Review. Dutch.
Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.
Hesselink DA, Ngyuen H, Wabbijn M, Gregoor PJ, Steyerberg EW, van Riemsdijk IC, Weimar W, van Gelder T. Hesselink DA, et al. Among authors: van riemsdijk ic, van gelder t. Br J Clin Pharmacol. 2003 Sep;56(3):327-30. doi: 10.1046/j.0306-5251.2003.01882.x. Br J Clin Pharmacol. 2003. PMID: 12919182 Free PMC article. Clinical Trial.
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
Hesselink DA, van Schaik RH, van der Heiden IP, van der Werf M, Gregoor PJ, Lindemans J, Weimar W, van Gelder T. Hesselink DA, et al. Among authors: van der werf m, van gelder t, van schaik rh, van der heiden ip. Clin Pharmacol Ther. 2003 Sep;74(3):245-54. doi: 10.1016/S0009-9236(03)00168-1. Clin Pharmacol Ther. 2003. PMID: 12966368
Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?
van Gelder T, Hesselink DA, van Hest RM, Mathôt RA, van Schaik R. van Gelder T, et al. Among authors: van hest rm, van schaik r. Ther Drug Monit. 2004 Aug;26(4):343-6. doi: 10.1097/00007691-200408000-00001. Ther Drug Monit. 2004. PMID: 15257061 Review. No abstract available.
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
Hesselink DA, van Gelder T, van Schaik RH, Balk AH, van der Heiden IP, van Dam T, van der Werf M, Weimar W, Mathot RA. Hesselink DA, et al. Among authors: van dam t, van gelder t, van der werf m, van schaik rh, van der heiden ip. Clin Pharmacol Ther. 2004 Dec;76(6):545-56. doi: 10.1016/j.clpt.2004.08.022. Clin Pharmacol Ther. 2004. PMID: 15592326
482 results